AAAAAA

   
Results: 1-14 |
Results: 14
ANXIOLYTIC AND SIDE-EFFECT PROFILE OF LY354740 - A POTENT, HIGHLY SELECTIVE, ORALLY-ACTIVE AGONIST FOR GROUP-II METABOTROPIC GLUTAMATE RECEPTORS
Authors: HELTON DR TIZZANO JP MONN JA SCHOEPP DD KALLMAN MJ
Citation: Dr. Helton et al., ANXIOLYTIC AND SIDE-EFFECT PROFILE OF LY354740 - A POTENT, HIGHLY SELECTIVE, ORALLY-ACTIVE AGONIST FOR GROUP-II METABOTROPIC GLUTAMATE RECEPTORS, The Journal of pharmacology and experimental therapeutics, 284(2), 1998, pp. 651-660
2-SUBSTITUTED MINO-2-((1SR,2SR)-2-CARBOXYCYCLOPROP-1-YL)GLYCINES AS POTENT AND SELECTIVE ANTAGONISTS OF GROUP-II METABOTROPIC GLUTAMATE RECEPTORS - 2 - EFFECTS OF AROMATIC-SUBSTITUTION, PHARMACOLOGICAL CHARACTERIZATION, AND BIOAVAILABILITY
Authors: ORNSTEIN PL BLEISCH TJ ARNOLD MB KENNEDY JH WRIGHT RA JOHNSON BG TIZZANO JP HELTON DR KALLMAN MJ SCHOEPP DD HERIN M
Citation: Pl. Ornstein et al., 2-SUBSTITUTED MINO-2-((1SR,2SR)-2-CARBOXYCYCLOPROP-1-YL)GLYCINES AS POTENT AND SELECTIVE ANTAGONISTS OF GROUP-II METABOTROPIC GLUTAMATE RECEPTORS - 2 - EFFECTS OF AROMATIC-SUBSTITUTION, PHARMACOLOGICAL CHARACTERIZATION, AND BIOAVAILABILITY, Journal of medicinal chemistry, 41(3), 1998, pp. 358-378
CLONIDINE ATTENUATES INCREASES IN SENSORIMOTOR REACTIVITY RESULTING FROM WITHDRAWAL OF CHRONIC NICOTINE
Authors: HELTON DR RASMUSSEN K KALLMAN MJ
Citation: Dr. Helton et al., CLONIDINE ATTENUATES INCREASES IN SENSORIMOTOR REACTIVITY RESULTING FROM WITHDRAWAL OF CHRONIC NICOTINE, Addiction, 92(5), 1997, pp. 626-626
SEROTONIN-1A ANTAGONISTS ATTENUATE THE EFFECTS OF NICOTINE WITHDRAWALON THE AUDITORY STARTLE RESPONSE
Authors: RASMUSSEN K KALLMAN MJ HELTON DR
Citation: K. Rasmussen et al., SEROTONIN-1A ANTAGONISTS ATTENUATE THE EFFECTS OF NICOTINE WITHDRAWALON THE AUDITORY STARTLE RESPONSE, Synapse, 27(2), 1997, pp. 145-152
LY354740 - A METABOTROPIC GLUTAMATE-RECEPTOR AGONIST WHICH AMELIORATES SYMPTOMS OF NICOTINE WITHDRAWAL IN RATS
Authors: HELTON DR TIZZANO JP MONN JA SCHOEPP DD KALLMAN MJ
Citation: Dr. Helton et al., LY354740 - A METABOTROPIC GLUTAMATE-RECEPTOR AGONIST WHICH AMELIORATES SYMPTOMS OF NICOTINE WITHDRAWAL IN RATS, Neuropharmacology, 36(11-12), 1997, pp. 1511-1516
LY303870, A CENTRALLY ACTIVE NEUROKININ-1 ANTAGONIST WITH A LONG-DURATION OF ACTION
Authors: IYENGAR S HIPSKIND PA GEHLERT DR SCHOBER D LOBB KL NIXON JA HELTON DR KALLMAN MJ BOUCHER S COUTURE R LI DL SIMMONS RMA
Citation: S. Iyengar et al., LY303870, A CENTRALLY ACTIVE NEUROKININ-1 ANTAGONIST WITH A LONG-DURATION OF ACTION, The Journal of pharmacology and experimental therapeutics, 280(2), 1997, pp. 774-785
DESIGN, SYNTHESIS, AND PHARMACOLOGICAL CHARACTERIZATION OF (-2-AMINOBICYCLO[3.1.0]HEXANE-2,6-DICARBOXYLIC ACID (LY354740) - A POTENT, SELECTIVE, AND ORALLY-ACTIVE GROUP-2 METABOTROPIC GLUTAMATE-RECEPTOR AGONIST POSSESSING ANTICONVULSANT AND ANXIOLYTIC PROPERTIES())
Authors: MONN JA VALLI MJ MASSEY SM WRIGHT RA SALHOFF CR JOHNSON BG HOWE T ALT CA RHODES GA ROBEY RL GRIFFEY KR TIZZANO JP KALLMAN MJ HELTON DR SCHOEPP DD
Citation: Ja. Monn et al., DESIGN, SYNTHESIS, AND PHARMACOLOGICAL CHARACTERIZATION OF (-2-AMINOBICYCLO[3.1.0]HEXANE-2,6-DICARBOXYLIC ACID (LY354740) - A POTENT, SELECTIVE, AND ORALLY-ACTIVE GROUP-2 METABOTROPIC GLUTAMATE-RECEPTOR AGONIST POSSESSING ANTICONVULSANT AND ANXIOLYTIC PROPERTIES()), Journal of medicinal chemistry, 40(4), 1997, pp. 528-537
TIME-DEPENDENT EFFECTS OF NICOTINE ADMINISTRATION AND CESSATION ON COGNITIVE PERFORMANCE
Authors: HELTON DR KALLMAN MJ JOHNSON JA TIZZANO JP
Citation: Dr. Helton et al., TIME-DEPENDENT EFFECTS OF NICOTINE ADMINISTRATION AND CESSATION ON COGNITIVE PERFORMANCE, Addiction, 91(1), 1996, pp. 140-140
THE CCK-B ANTAGONIST LY288513 BLOCKS THE EFFECTS OF NICOTINE WITHDRAWAL ON AUDITORY STARTLE
Authors: RASMUSSEN K CZACHURA JF KALLMAN MJ HELTON DR
Citation: K. Rasmussen et al., THE CCK-B ANTAGONIST LY288513 BLOCKS THE EFFECTS OF NICOTINE WITHDRAWAL ON AUDITORY STARTLE, NeuroReport, 7(5), 1996, pp. 1050-1052
CENTRAL-NERVOUS-SYSTEM CHARACTERIZATION OF THE NEW CHOLECYSTOKININ, ANTAGONIST LY288513
Authors: HELTON DR BERGER JE CZACHURA JF RASMUSSEN K KALLMAN MJ
Citation: Dr. Helton et al., CENTRAL-NERVOUS-SYSTEM CHARACTERIZATION OF THE NEW CHOLECYSTOKININ, ANTAGONIST LY288513, Pharmacology, biochemistry and behavior, 53(3), 1996, pp. 493-502
GENERAL PHARMACOLOGY OF INSULIN LISPRO IN ANIMALS
Authors: HELTON DR ZIMMERMANN JL HEIM A JONES TW TURK JA KALLMAN MJ
Citation: Dr. Helton et al., GENERAL PHARMACOLOGY OF INSULIN LISPRO IN ANIMALS, Arzneimittel-Forschung, 46(1), 1996, pp. 91-97
INTRACEREBRAL INJECTIONS OF METABOTROPIC GLUTAMATE-RECEPTOR AGONISTS CAN INDUCE OR PROTECT AGAINST LIMBIC SEIZURES IN MICE
Authors: TIZZANO JP GRIFFEY KI VALLI MJ HELTON DR KALLMAN MJ SCHOEPP DD MONN JA
Citation: Jp. Tizzano et al., INTRACEREBRAL INJECTIONS OF METABOTROPIC GLUTAMATE-RECEPTOR AGONISTS CAN INDUCE OR PROTECT AGAINST LIMBIC SEIZURES IN MICE, Behavioural pharmacology, 6(5-6), 1995, pp. 633-634
EFFECTS OF VARIATION IN CHRONIC DOSE OF COCAINE ON CONTINGENT TOLERANCE AS ASSESSED IN A MILK-DRINKING TASK
Authors: BOWEN SE FOWLER SC KALLMAN MJ
Citation: Se. Bowen et al., EFFECTS OF VARIATION IN CHRONIC DOSE OF COCAINE ON CONTINGENT TOLERANCE AS ASSESSED IN A MILK-DRINKING TASK, Psychopharmacology, 113(1), 1993, pp. 67-75
THE EFFECTS OF VARIOUS LEVELS OF ASCORBIC-ACID ON THE RESPONSE OF THEODS RAT TO TRIMETHYLTIN
Authors: BANNON AW VERLANGIERI AJ WILSON MC KALLMAN MJ
Citation: Aw. Bannon et al., THE EFFECTS OF VARIOUS LEVELS OF ASCORBIC-ACID ON THE RESPONSE OF THEODS RAT TO TRIMETHYLTIN, Neurotoxicology, 14(4), 1993, pp. 437-444
Risultati: 1-14 |